Dark

AMGN
Amgen Inc
stock NASDAQ

At Close

Feb 23, 2026 3:59:58 PM EST

379.49USD+1.265%(+4.74)2,945,239

361.19Bid 394.80Ask 33.61Spread

Pre-market

Feb 23, 2026 9:14:30 AM EST

374.73USD-0.005%(-0.02)363

After-hours

Feb 23, 2026 4:48:30 PM EST

378.11USD-0.363%(-1.38)7,291

OverviewOptionsHistoricalExchangesShortsMore

open chart

Market Cap

204.54B

CEO

Robert Bradway

Headquarters

Thousand Oaks, California, USA

Industry

Drug Manufacturers-General

Next Earnings

Apr 29, 2026 (64d)

Last Dividend

Feb 13, 20262.520

Last Split

Nov 22, 19992for1

ALXN CELG GILD BIIB GSK BMY JNJ PFE ABBV XLV

AMGN Stats

Avg. Vol. 10 Day

2,815,099

Avg. Vol. 30 Day

2,964,293

Employees

20,800

Market Cap

204,543,838,602

Shares Out.

539,067,675

On/Off Exchange

58%/43%

6 Month Beta

0.58

1 Year Beta

0.46

2 Year Beta

0.50

3 Year Beta

0.50

52 Week Low

261.43

52 Week High

385.12

SMA50

341.34

SMA200

306.96

1 Week

+1.63%

1 Month

+10.06%

3 Month

+13.50%

6 Month

+29.18%

1 Year

+22.51%

2 Year

+31.21%

5 Year

+63.23%

Profile

Amgen Inc. is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. One of the worlds largest independent biotechnology companies, Amgen was established in Thousand Oaks, California, in 1980.

AMGN Stock Summary

Amgen Inc (NASDAQ:AMGN) stock price today is $379.49, and today's volume is 2,945,239. AMGN is up 1.265% today. The 30 day average volume is 2,964,293. AMGN market cap is 204.54B with 539,067,675 shares outstanding.

document.getElementById("fsld9q").onerror = function(){this.style.display='none';}; .dark-mode .Hp9xBH{ color: white; background-color: #333333; border: 2px solid white; }.light-mode .Hp9xBH{ color: #333333; background-color: white; border: 2px solid #333333; }AMGNAmgen Incstock NASDAQ

AMGN Stock Summary

AMGN
Amgen Inc
stock NASDAQ